Corrección del autor: La reprogramación de la traducción específica del codón promueve la resistencia a la terapia dirigida

¹Laboratory of Cancer Signaling, University of Liège, Liège, Belgium.
²GIGA-institute, University of Liège, Liège, Belgium.
³Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
⁴Center for Cancer Biology, VIB, Leuven, Belgium.
⁵Institute for Pathology, University Hospital Cologne, Cologne, Germany.
⁶Centre for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium.
⁷Max Planck Research Group for RNA Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
⁸Faculty of Medicine, University of Münster, Münster, Germany.
⁹Cells-in-Motion Cluster of Excellence, University of Münster, Münster, Germany.
¹⁰Laboratory of Medical Chemistry, University of Liège, Liège, Belgium.
¹¹Department of Radiotherapy (MAASTRO)/GROW, School for Developmental Biology and Oncology, Maastricht University, Maastricht, The Netherlands.
¹²Metabolomics Core Facility, Center for Cancer Biology, VIB, Leuven, Belgium.
¹³Unit of Animal Genomics, University of Liège, Liège, Belgium.
¹⁴Medical Oncology, CHU Sart Tilman Liège, University of Liège, Liège, Belgium.
¹⁵WELBIO, University of Liège, Liège, Belgium.
¹⁶Laboratory of Cancer Signaling, University of Liège, Liège, Belgium. Pierre.Close@uliege.be.
¹⁷GIGA-institute, University of Liège, Liège, Belgium. Pierre.Close@uliege.be.
¹⁸WELBIO, University of Liège, Liège, Belgium. Pierre.Close@uliege.be.

Resumen